NASDAQ : CRSP
CRISPR Therapeutics AG — Financial statements
Healthcare · Biotechnology · Switzerland
Last price 54.26 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.25B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
CRISPR Therapeutics AG (CRSP) reported revenue of 13.39M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 13.39M | 3.51M | 37.31M | 371.21M | 1.20M | 914.96M |
| Cost of Revenue | 475.19M | 498.29M | 430.90M | 517.58M | 571.89M | 441.75M |
| Gross Profit | -461.80M | -494.78M | -393.59M | -146.38M | -570.70M | 473.22M |
| Selling, General & Admin | 70.07M | 73.54M | 72.98M | 76.16M | 102.46M | 99.69M |
| Operating Expenses | 70.07M | 73.54M | 72.98M | 76.16M | 102.46M | 99.69M |
| Operating Income | -531.87M | -568.32M | -466.57M | -222.54M | -673.16M | 373.53M |
| Interest & Investment Income | 22.66M | 6.00M | ||||
| Other Non Operating Income (Expenses) | 86.23M | 86.61M | 103.90M | 71.82M | ||
| EBT Excluding Unusual Items | -445.63M | -481.71M | -362.67M | -150.72M | -650.50M | 379.53M |
| Pretax Income | -448.11M | -577.97M | -362.67M | -150.72M | -650.50M | 379.53M |
| Income Tax Expense | 3.03M | 3.63M | 3.59M | 2.89M | -325.00K | 1.87M |
| Earnings From Continuing Operations | -451.14M | -581.60M | -366.25M | -153.61M | -650.17M | 377.66M |
| Net Income | -451.14M | -581.60M | -366.25M | -153.61M | -650.17M | 377.66M |
| Net Income to Common | -451.14M | -581.60M | -366.25M | -153.61M | -650.17M | 377.66M |
| Shares Outstanding (Basic) | 94.81M | 89.93M | 84.36M | 79.22M | 77.75M | 75.95M |
| Shares Outstanding (Diluted) | 94.81M | 89.93M | 84.36M | 79.22M | 77.75M | 80.39M |
| EPS (Basic) | -4.76 | -6.47 | -4.34 | -1.94 | -8.36 | 4.97 |
| EPS (Diluted) | -4.76 | -6.47 | -4.34 | -1.94 | -8.36 | 4.70 |
| Free Cash Flow | -371.32M | -345.93M | -144.68M | -269.85M | -532.93M | 457.27M |
| Free Cash Flow Per Share | -3.92 | -3.85 | -1.72 | -3.41 | -6.86 | 5.69 |
| Gross Margin | -39.43% | 51.72% | ||||
| Operating Margin | -3,971.53% | -16,191.40% | -1,250.38% | -59.95% | -56,190.40% | 40.82% |
| Profit Margin | -3,368.72% | -16,569.77% | -981.54% | -41.38% | -54,271.70% | 41.28% |
| Free Cash Flow Margin | -2,772.74% | -9,855.50% | -387.72% | -72.69% | -44,484.89% | 49.98% |
| EBITDA | -513.17M | -548.84M | -447.31M | -202.70M | -648.99M | 391.48M |
| EBITDA Margin | -54.61% | 42.79% | ||||
| D&A For EBITDA | 18.69M | 19.48M | 19.26M | 19.84M | 24.17M | 17.95M |
| EBIT | -531.87M | -568.32M | -466.57M | -222.54M | -673.16M | 373.53M |
| EBIT Margin | -59.95% | 40.82% | ||||
| Effective Tax Rate | 0.49% | |||||
| Revenue as Reported | 13.39M | 3.51M | 37.31M | 371.21M | 1.20M | 914.96M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 291.34M | 347.56M | 298.26M | 389.48M | 211.88M | 923.03M |
| Short-Term Investments | 2.07B | 1.63B | 1.61B | 1.30B | 1.60B | 1.46B |
| Cash & Short-Term Investments | 2.36B | 1.98B | 1.90B | 1.69B | 1.82B | 2.38B |
| Accounts Receivable | 25.00M | 200.00M | 305.00K | |||
| Other Receivables | 6.50M | 11.20M | 8.40M | |||
| Receivables | 25.00M | 206.50M | 11.20M | 8.71M | ||
| Prepaid Expenses | 7.02M | 5.95M | 8.31M | 7.89M | 26.01M | 29.68M |
| Restricted Cash | 400.00K | 3.89M | 500.00K | |||
| Total Current Assets | 2.37B | 1.99B | 1.94B | 1.91B | 1.85B | 2.42B |
| Property, Plant & Equipment | 233.66M | 247.57M | 277.55M | 305.94M | 320.56M | 312.04M |
| Long-Term Investments | 35.90M | 22.60M | 12.90M | 1.97M | 53.13M | |
| Other Intangible Assets | 16.00K | 71.00K | 125.00K | |||
| Other Long-Term Assets | 9.44M | 9.40M | 14.45M | 13.57M | 16.27M | 22.20M |
| Total Assets | 2.65B | 2.27B | 2.24B | 2.23B | 2.24B | 2.75B |
| Accounts Payable | 11.31M | 11.14M | 14.71M | 38.15M | 27.43M | 14.82M |
| Accrued Expenses | 30.71M | 34.46M | 39.56M | 40.67M | 61.33M | 77.77M |
| Current Portion of Leases | 18.65M | 18.58M | 17.29M | 15.62M | 15.84M | 12.16M |
| Current Income Taxes Payable | 494.00K | 1.11M | 451.00K | 438.00K | 135.00K | 724.00K |
| Current Unearned Revenue | 15.19M | 15.77M | 3.85M | 4.11M | 1.01M | |
| Other Current Liabilities | 56.55M | 68.06M | 11.93M | 9.81M | 16.38M | 13.40M |
| Total Current Liabilities | 132.90M | 149.12M | 87.78M | 108.79M | 121.11M | 119.88M |
| Long-Term Debt | 586.20M | |||||
| Long-Term Leases | 178.90M | 188.17M | 206.41M | 223.01M | 228.18M | 212.87M |
| Long-Term Unearned Revenue | 12.32M | 14.01M | 12.32M | 12.32M | ||
| Other Long-Term Liabilities | 6.22M | 6.14M | 3.44M | 958.00K | 5.97M | 7.34M |
| Total Liabilities | 904.22M | 343.43M | 309.95M | 346.77M | 367.58M | 352.42M |
| Common Stock | 3.13M | 3.09M | 2.70M | 2.50M | 2.44M | 2.39M |
| Additional Paid-In Capital | 3.91B | 3.86B | 3.29B | 2.88B | 2.73B | 2.60B |
| Retained Earnings | -2.16B | -1.95B | -1.37B | -999.70M | -846.09M | -195.91M |
| Treasury Stock | -60.00K | -60.00K | -62.00K | -62.00K | -63.00K | -63.00K |
| Comprehensive Income & Other | -4.63M | 4.82M | 1.84M | 1.91M | -15.65M | -5.07M |
| Total Common Equity | 1.75B | 1.92B | 1.93B | 1.88B | 1.88B | 2.40B |
| Shareholders' Equity | 1.75B | 1.92B | 1.93B | 1.88B | 1.88B | 2.40B |
| Total Liabilities & Equity | 2.65B | 2.27B | 2.24B | 2.23B | 2.24B | 2.75B |
| Total Debt | 783.75M | 206.75M | 223.69M | 238.63M | 244.02M | 225.03M |
| Net Cash (Debt) | 1.58B | 1.77B | 1.68B | 1.46B | 1.62B | 2.15B |
| Net Cash Per Share | 16.67 | 19.67 | 19.92 | 18.39 | 20.89 | 26.79 |
| Filing Date Shares Outstanding | 96.69M | 95.99M | 85.77M | 80.28M | 78.65M | 77.07M |
| Total Common Shares Outstanding | 96.66M | 95.89M | 85.74M | 80.04M | 78.51M | 76.99M |
| Working Capital | 2.24B | 1.84B | 1.85B | 1.80B | 1.73B | 2.30B |
| Book Value Per Share | 18.07 | 20.04 | 22.53 | 23.52 | 23.89 | 31.17 |
| Tangible Book Value | 1.75B | 1.92B | 1.93B | 1.88B | 1.88B | 2.40B |
| Tangible Book Value Per Share | 18.07 | 20.04 | 22.53 | 23.52 | 23.89 | 31.16 |
| Machinery | 57.66M | 56.28M | 54.40M | 53.26M | 49.62M | 36.25M |
| Construction In Progress | 3.22M | 3.96M | 6.12M | 8.86M | 6.16M | 52.40M |
| Leasehold Improvements | 146.79M | 146.67M | 145.85M | 143.26M | 141.68M | 86.73M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -451.14M | -581.60M | -366.25M | -153.61M | -650.17M | 377.66M |
| Depreciation & Amortization | 18.69M | 19.48M | 19.26M | 19.84M | 24.17M | 17.95M |
| Asset Writedown & Restructuring Costs | 2.47M | 96.25M | 2.50M | |||
| Stock-Based Compensation | 68.32M | 72.50M | 86.57M | 81.03M | 97.95M | 102.39M |
| Other Operating Activities | -23.22M | -23.53M | -38.62M | -16.55M | 12.47M | 14.11M |
| Change in Accounts Receivable | 25.00M | 175.00M | -200.00M | 305.00K | -161.00K | |
| Change in Accounts Payable | -1.73M | 44.89M | -27.28M | -20.25M | 5.16M | 37.51M |
| Change in Unearned Revenue | 737.00K | -397.00K | -1.95M | 5.79M | -1.01M | -783.00K |
| Change in Other Net Operating Assets | 15.43M | 2.38M | 10.50M | 20.87M | 15.39M | -9.71M |
| Operating Cash Flow | -369.58M | -345.01M | -142.77M | -260.38M | -495.74M | 538.97M |
| Capital Expenditures | -1.74M | -914.00K | -1.90M | -9.47M | -37.19M | -81.70M |
| Sale (Purchase) of Intangibles | -2.47M | -25.00M | -2.50M | |||
| Investment in Securities | -544.21M | -5.89M | -278.58M | 386.62M | -221.47M | -953.73M |
| Investing Cash Flow | -548.43M | -31.80M | -280.48M | 374.65M | -258.65M | -1.04B |
| Net Debt Issued (Repaid) | 600.00M | |||||
| Issuance of Common Stock | 427.64M | 426.03M | 331.98M | 62.66M | 38.59M | 250.94M |
| Other Financing Activities | -15.37M | |||||
| Financing Cash Flow | 1.01B | 426.03M | 331.98M | 62.66M | 38.59M | 250.94M |
| Foreign Exchange Rate Adjustments | -52.00K | 95.00K | -21.00K | 73.00K | -80.00K | -11.00K |
| Miscellaneous Cash Flow Adjustments | -1.00K | |||||
| Net Cash Flow | 94.20M | 49.30M | -91.29M | 177.01M | -715.88M | -245.52M |
| Free Cash Flow | -371.32M | -345.93M | -144.68M | -269.85M | -532.93M | 457.27M |
| Free Cash Flow Margin | -2,772.74% | -9,855.50% | -387.72% | -72.69% | -44,484.89% | 49.98% |
| Free Cash Flow Per Share | -3.92 | -3.85 | -1.72 | -3.41 | -6.86 | 5.69 |
| Levered Free Cash Flow | -215.85M | -205.62M | -29.27M | -238.97M | -337.58M | 284.82M |
| Unlevered Free Cash Flow | -216.69M | -205.62M | -29.27M | -238.97M | -337.58M | 284.82M |
| Change in Working Capital | 14.44M | 71.88M | 156.27M | -193.59M | 19.84M | 26.86M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.97B | 5.00B | 3.36B | 4.97B | 3.18B | 5.80B |
| Enterprise Value | 3.39B | 3.26B | 1.65B | 3.47B | 1.45B | 3.53B |
| Last Close Price | 51.42 | 52.44 | 39.36 | 62.60 | 40.65 | 75.78 |
| PE Ratio | 15.36 | |||||
| PS Ratio | 371.26 | 1,423.80 | 90.03 | 13.39 | 2,656.64 | 6.34 |
| PB Ratio | 2.85 | 2.60 | 1.74 | 2.64 | 1.70 | 2.42 |
| P/TBV Ratio | 2.85 | 2.60 | 1.74 | 2.64 | 1.70 | 2.42 |
| P/FCF Ratio | 12.68 | |||||
| P/OCF Ratio | 10.76 | |||||
| EV/Sales Ratio | 253.24 | 930.04 | 44.26 | 9.36 | 1,211.76 | 3.85 |
| EV/EBITDA Ratio | 9.01 | |||||
| EV/EBIT Ratio | 9.44 | |||||
| EV/FCF Ratio | 7.71 | |||||
| Debt / Equity Ratio | 0.45 | 0.11 | 0.12 | 0.13 | 0.13 | 0.09 |
| Debt / EBITDA Ratio | 0.53 | |||||
| Debt / FCF Ratio | 0.49 | |||||
| Net Debt / Equity Ratio | -0.91 | -0.92 | -0.87 | -0.77 | -0.87 | -0.90 |
| Net Debt / EBITDA Ratio | 3.08 | 3.22 | 3.76 | 7.19 | 2.50 | -5.50 |
| Net Debt / FCF Ratio | 4.26 | 5.11 | 11.61 | 5.40 | 3.05 | -4.71 |
| Asset Turnover | 0.01 | 0.00 | 0.02 | 0.17 | 0.00 | 0.40 |
| Quick Ratio | 17.79 | 13.25 | 21.97 | 17.47 | 15.08 | 19.92 |
| Current Ratio | 17.85 | 13.32 | 22.07 | 17.54 | 15.30 | 20.17 |
| Return on Equity (ROE) | -26.10% | -30.18% | -19.20% | -8.17% | -30.42% | 18.59% |
| Return on Assets (ROA) | -14.20% | -15.76% | -13.04% | -6.22% | -16.85% | 10.20% |
| Return on Invested Capital (ROIC) | -325.94% | -280.87% | -137.29% | -60.81% | -244.99% | 151.49% |
| Return on Capital Employed (ROCE) | -21.10% | -26.90% | -21.70% | -10.50% | -31.70% | 14.20% |
| Earnings Yield | -9.26% | -11.64% | -10.90% | -3.09% | -20.43% | 6.51% |
| FCF Yield | -7.47% | -6.92% | -4.31% | -5.43% | -16.74% | 7.89% |
| Buyback Yield / Dilution | -10.33% | -6.60% | -6.49% | -1.90% | 3.29% | -21.90% |